Skip to main content

Table 2 Haemoglobin, ferritin and MCV values at end of study

From: Effect of a short course of iron polymaltose on acquisition of malarial parasitaemia in anaemic Indonesian schoolchildren: a randomized trial

Variable

IPM group

Placebo group

Haemoglobin level available, n

290

288

 Haemoglobin level, g/dl, mean ± SD

12.1 ± 1.0

12.0 ± 1.1

 ∆ Haemoglobin, g/dl, mean ± SD

0.09 ± .91

0.08 ± .85

Ferritin level available, n

277

276

 Ferritin level, µg/l, median (IQR)

47.7 (30.8–70.4)

45.2 (28.8–65.8)

 ∆ Ferritin, µg/l, median (IQR)

3.0 (−9.9 to 17.7)

1.3 (−9.4 to 14.6)

Children with iron deficiency at baseline, na

77

82

 Children remaining iron deficient at wk 16, n (%)

43 (55.8)

53 (64.6)

 ∆ Ferritin, µg/l, median (IQR)

6.1 (2.6–17.5)

5.9 (−0.1 to 14.5)

Mean corpuscular volume (MCV) available, n

290

288

 MCV, fl, mean ± SD

74.7 ± 5.4

74 ± 5.6

 ∆ MCV, fl, mean ± SD

0.5 ± 2.2

0.4 ± 1.9

Children with microcytosis at baseline, nb

147

164

 Persistent microcytosis at wk 16, n (%)

133 (87.5)

148 (87.6)

 ∆ MCV, fl, mean ± SD

1.1 (0.7–1.5)

0.7 (0.4–1.1)

  1. There were no statistical significant differences in any parameter between the groups
  2. aIron deficiency defined as serum ferritin concentration < 30 μg/l
  3. bMicrocytosis defined as MCV ≤ 75 fl
  4. ∆ = Mean or median change between baseline and week 16